Compare Oscar Health Inc (OSCR) vs Otis Worldwide Corp (OTIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs Otis Worldwide Corp — how do they compare? Oscar Health Inc trades at $33.37 (market cap $10.22B), while Otis Worldwide Corp trades at $65.95 (market cap $25.17B). The key difference: Otis Worldwide Corp is far larger — about 2.5× Oscar Health Inc's market cap, and Otis Worldwide Corp pays a 2.66% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and Otis Worldwide Corp for 66 Days on average.
| OSCR | OTIS | |
|---|---|---|
Market Cap | $10.22B | $25.17B |
Volume | 4,123,394 | 4,542,442 |
Sector | Health | Industrials |
52-Week High | $33.81 | $93.62 |
52-Week Low | $10.85 | $64.05 |
Typical Hold Time | 15 Days | 66 Days |
Enterprise Value | $6.57B | $33.20B |
Dividend Yield | — | 2.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OSCR trades at $33.10, up 0.58% with a bullish technical signal and strong institutional support. Recent earnings show volatility with Q1 and Q2 2026 beats but a Q4 2025 miss. Revenue grew from $11.7B in 2025 to $15.3B in 2026, with net income turning positive at $551M. Analyst consensus is mixed with 30.77% buy ratings and a $34.00 price target, slightly above current levels.
The outlook is cautiously optimistic with strong revenue growth and profitability improvements, though risks include medical cost pressures and competitive ACA market dynamics. Upside potential exists if margin expansion continues, but investors should monitor execution against guidance and healthcare sector headwinds.
Otis Worldwide trades at $66.11, up 0.56% today but near its 52-week low, with a bearish technical signal and mixed earnings history. The company reported revenue of $14.43B in 2025 with a net income margin of 10.17%, though recent quarters have seen EPS misses. Analyst consensus is split between Buy and Hold, with a price target of $87.00. News highlights margin pressures from China and labor costs, alongside CEO succession plans for 2027.
The outlook is cautious due to near-term margin headwinds and weak equipment demand, but the service segment's growth and dominant market position offer long-term stability. Risks include China exposure and cost inflation, while institutional buying and a discounted valuation present potential upside if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About Otis Worldwide Corp
Otis is the largest global elevator and escalator supplier by revenue with around one quarter of share excluding Japan. In 1854 Otis' founder and namesake, Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed.The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15-20 year useful life of an elevator. As the largest global OEM, over decades Otis has built a base of 2 million elevators under service. Its business model is much the same as that of its competitors Kone, Schindler, and Thyssenkrupp.
Read more on OTIS →
